vTv Therapeutics
VTVT
$17.22
Share price
-6.43%
Change (1 day)
2,165.30%
Change (1 year)
Categories
P/S ratio for vTv Therapeutics (VTVT)
P/S ratio as of June 2024 (TTM): 41.9
According to vTv Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 41.8848. At the end of 2023 the company had a P/S ratio of N/A.
P/S ratio history for vTv Therapeutics from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | N/A | -100% |
| 2022 | 26.8 | 60.92% |
| 2021 | 16.6 | -24.29% |
| 2020 | 22.0 | -44.2% |
| 2019 | 39.4 | 325.25% |
| 2018 | 9.26 | -98.63% |
| 2017 | 678 | 171.1% |
| 2016 | 250 | -41.94% |
| 2015 | 431 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.12 | -97.32% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 120.84% | 🇺🇸 USA |